Trial Profile
A Trial Investigating the Pharmacokinetic Properties of NN1250 in Healthy Chinese Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 31 May 2019
Price :
$35
*
At a glance
- Drugs Insulin degludec (Primary)
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Novo Nordisk
- 28 Nov 2011 Actual end date (Nov 2011) added as reported by ClinicalTrials.gov.
- 28 Nov 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 11 Nov 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.